Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H17NO3.ClH |
Molecular Weight | 247.719 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=C(OC)C(=C1)[C@@H](O)[C@H](C)N
InChI
InChIKey=YGRFXPCHZBRUKP-WJRQTEJMSA-N
InChI=1S/C11H17NO3.ClH/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3;/h4-7,11,13H,12H2,1-3H3;1H/t7-,11-;/m0./s1
Molecular Formula | C11H17NO3 |
Molecular Weight | 211.2576 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Methoxamine is an alpha-adrenergic agonist that induces prolonged peripheral vasoconstriction, and can also stimulate the release of arginine vasopressin in humans. In clinical trials, methoxamine was found to improve fecal incontinence. It had been marketed by Glaxo-Smith-Kline under the brand name Vasoxyl but has been discontinued. Methoxamine was also found to stimulate the induction of hiPSC-derived hepatoblasts to ALBUMIN+ cells.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P35348|||B0ZBD9|||Q6RUJ8 Gene ID: 148.0 Gene Symbol: ADRA1A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/7875228 |
4.86 null [pKi] | ||
Target ID: P25100 Gene ID: 146.0 Gene Symbol: ADRA1D Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/19493707 |
1299.27 nM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Vasoxyl Approved UseUnknown Launch Date1981 |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
15.69 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24499494/ |
10 mg single, rectal dose: 10 mg route of administration: Rectal experiment type: SINGLE co-administered: |
METHOXAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
178.95 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24499494/ |
10 mg single, rectal dose: 10 mg route of administration: Rectal experiment type: SINGLE co-administered: |
METHOXAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
6.15 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/24499494/ |
10 mg single, rectal dose: 10 mg route of administration: Rectal experiment type: SINGLE co-administered: |
METHOXAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Doses
Dose | Population | Adverse events |
---|---|---|
15 mg single, rectal Recommended |
healthy, 18 - 60 years n = 24 Health Status: healthy Age Group: 18 - 60 years Sex: M+F Population Size: 24 Sources: |
DLT: Heart rate decreased... Dose limiting toxicities: Heart rate decreased (8 patients) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Heart rate decreased | 8 patients DLT |
15 mg single, rectal Recommended |
healthy, 18 - 60 years n = 24 Health Status: healthy Age Group: 18 - 60 years Sex: M+F Population Size: 24 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Microphysiometric analysis of human alpha1a-adrenoceptor expressed in Chinese hamster ovary cells. | 1999 Jun |
|
Profound bradycardia and hypotension following spinal anaesthesia in a patient receiving an ACE inhibitor: an important 'drug' interaction? | 1999 Nov |
|
Effect of methoxamine on maximum urethral pressure in women with genuine stress incontinence: a placebo-controlled, double-blind crossover study. | 2001 |
|
Nitric oxide modulates acetylcholine-induced vasodilatation in the hepatic arterial vasculature of the dual-perfused rat liver. | 2001 Apr |
|
Effect of the blood substitute diaspirin crosslinked hemoglobin in rat mesenteric and human radial collateral arteries. | 2001 Apr |
|
Erection and NO override the vasoconstrictive effect of alpha-adrenergic stimulation in the rat penile vasculature. | 2001 Aug |
|
Alpha-vascular responses after short-term and long-term inhibition of nitric oxide synthesis. | 2001 Feb |
|
Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects. | 2001 Feb |
|
Mechanisms of the increased pressor response to vasopressors in the mesenteric bed of nitric oxide-deficient hypertensive rats. | 2001 Feb 2 |
|
Assessment of the pro-arrhythmic potential of anti-arrhythmic drugs: an experimental approach. | 2001 Jan |
|
d,l-sotalol enhances baroreflex sensitivity in conscious rats surviving acute myocardial infarction. | 2001 Jul |
|
Characterization of alpha1-adrenoceptor-mediated contraction in the mouse thoracic aorta. | 2001 Jul 20 |
|
Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists. | 2001 Jul 6 |
|
Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity. | 2001 Jun |
|
Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats. | 2001 Jun |
|
The influence of phosphodiesterase inhibitor, rolipram, on hemodynamics in lipopolysaccharide-treated rats. | 2001 Mar |
|
Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. | 2001 Mar |
|
Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model. | 2001 May |
|
Hypoxia alters the sensitivity of the L-type Ca(2+) channel to alpha-adrenergic receptor stimulation in the presence of beta-adrenergic receptor stimulation. | 2001 May 25 |
|
Structure-activity relationships of diadenosine polyphosphates (Ap(n)As), adenosine polyphospho guanosines (Ap(n)Gs) and guanosine polyphospho guanosines (Gp(n)Gs) at P2 receptors in the rat mesenteric arterial bed. | 2001 Nov |
|
MRI assessment of LV relaxation by untwisting rate: a new isovolumic phase measure of tau. | 2001 Nov |
|
Stimulation of alpha1-adrenoceptors inhibits memory consolidation in the chick. | 2001 Oct |
|
The noradrenergic inhibition of an apamin-sensitive, small-conductance Ca2+-activated K+ channel in hypothalamic gamma-aminobutyric acid neurons: pharmacology, estrogen sensitivity, and relevance to the control of the reproductive axis. | 2001 Oct |
|
Alpha2-adrenoceptor ligands inhibit alpha1-adrenoceptor-mediated contraction of isolated rat arteries. | 2002 Aug |
|
Alpha1-adrenoceptor-mediated breakdown of phosphatidylinositol 4,5-bisphosphate inhibits pinacidil-activated ATP-sensitive K+ currents in rat ventricular myocytes. | 2002 Aug 9 |
|
Dual adrenergic control of in vivo choline levels in the mouse major salivary glands. | 2002 Feb |
|
Activation of alpha 1-adrenoceptors is not essential for the mediation of ischaemic preconditioning in rat heart. | 2002 Jan-Feb |
|
Norepinephrine elicits beta2-receptor-mediated dilation of isolated human coronary arterioles. | 2002 Jul 30 |
|
Blood-brain barrier breakdown in septic encephalopathy and brain tumours. | 2002 Jun |
|
Compression and expansion wavefront travel in canine ascending aortic flow: wave intensity analysis. | 2002 Mar |
|
Potential anaphylactic shock with abciximab readministration. | 2002 Mar |
|
ANP potentiates nonarterial baroreflex bradycardia: evidence from sinoaortic denervation in rats. | 2002 May 31 |
|
Effects of chronic administration of L-arginine on vasoactive responses induced by endothelin-1 and its plasma level in streptozotocin-induced diabetic rats. | 2002 Oct |
|
Use of pharmaceuticals in noninvasive cardiovascular diagnosis. | 2002 Sep-Oct |
|
Effects of halothane and isoflurane on acetylcholine-induced, endothelium-dependent vasodilation in perfused rat mesenteric arterial beds. | 2003 |
|
Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. | 2003 Apr |
|
Effects of hypochlorite and hydrogen peroxide on cardiac autonomic receptors and vascular endothelial function. | 2003 Apr |
|
Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney, and aorta. | 2003 Aug |
|
Evidence for the role of alpha1D- and alpha1A-adrenoceptors in contraction of the rat mesenteric artery. | 2003 Feb |
|
Guanylyl cyclase receptors mediate cardiopulmonary vagal reflex actions of ANP. | 2003 Feb |
|
Functional development of the rat urinary bladder after pre- or postpubertal castration. | 2003 Feb |
|
Stability of actin cytoskeleton and PKC-delta binding to actin regulate NKCC1 function in airway epithelial cells. | 2003 Feb |
|
L-Erythro-methoxamine is more potent than phenylephrine in effecting contraction of internal anal sphincter in vitro. | 2003 Jul |
|
Modulation of intracellular Ca2+ via L-type calcium channels in heart cells by the autoantibody directed against the second extracellular loop of the alpha1-adrenoceptors. | 2003 Mar |
|
Role of the eNOS Glu298Asp variant on the GNB3825T allele dependent determination of alpha-adrenergic coronary constriction. | 2003 May |
|
Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. | 2003 Oct |
|
Fish Balistes capriscus skin extract-induced relaxation in mesenteric arterial bed of rat. | 2003 Oct |
|
Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis. | 2003 Oct 6 |
|
Novel form of long-term synaptic depression in rat hippocampus induced by activation of alpha 1 adrenergic receptors. | 2004 Feb |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00893607
Patients suffering fecal incontinence were administered 10 mg of Methoxamine as a slow release suppository into the anal canal.
Route of Administration:
Rectal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29196668
Hepatic differentiation of hiPSC colonies grown on SNL feeder cells occurred in three culture stages over 18 - 21 days concluding with hepatocyte culture medium containing 20 ng/ml recombinant human hepatocyte growth factor and 20 ng/ml recombinant human Oncostatin M for 7 - 8 days. Methoxamine from a commercial compound screen was included in the stage 3 hepatocyte culture media. After 7 days incubation cells were subjected to anti-ALBUMIN immunostaining, and the number and induction rate of ALBUMIN+ cells was examined. Methoxamine was the sole effective compound among the 1,120 tested. The induction rate of hiPSC-derived hepatoblasts into ALBUMIN+ cells in the populations treated with methoxamine was 33.7%. Methoxamine was then titrated against hiPSC-derived hepatoblasts cultures across a range of 0.001 μM to 100 μM and demonstrated a dose-dependent induction activity with the highest efficiency at 1 μM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:57:11 GMT 2023
by
admin
on
Sat Dec 16 17:57:11 GMT 2023
|
Record UNII |
8MB4MJ9R7L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29709
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
203187
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | RxNorm | ||
|
DBSALT000971
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
m7328
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | Merck Index | ||
|
8MB4MJ9R7L
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
200-499-7
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
C66120
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
57333099
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
SUB03226MIG
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
CHEMBL524
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
100000085973
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
61-16-5
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
757102
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
3362
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY | |||
|
DTXSID7045782
Created by
admin on Sat Dec 16 17:57:11 GMT 2023 , Edited by admin on Sat Dec 16 17:57:11 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |